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Conclusions: In this first-in-human feasibility study, the theoretical concerns of higher-
frequency IVUS were not documented in clinical settings, demonstrating a comparable
ability of 60MHz imaging in measurements of diseased coronary arteries as compared
with conventional 40MHz imaging.
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Background: The vascular tissue reaction to acute incomplete stent apposition (ISA) is
scarcely known. The aim of this study is characterizing the vascular response to acute ISA
in vivo and looking for predictors of incomplete healing.
Methods: Optical coherence tomography studies from 3 randomized trials including
different types of stents were sequentially analysed after implantation and at 6-13 months.
Segments with acute ISA were matched with the follow-up study using fiduciary
landmarks. The pattern of healing was categorized according to morphologic criteria.
Volumetric and per strut analysis (apposition and coverage) were performed. Predictors
for ISA correction and for completeness of coverage were sought.
Results: 66 stents (43 patients) were sequentially analyzed. 78 ISA segments were
identified. ISA volume decreased and 71.5% of the ISA segments were spontaneously
corrected at follow-up. Coverage of acute ISA segments is delayed with respect to
well-apposed segments (RR 2.37; 95% CI 2.01 – 2.78). ISA coverage depended on the
type of stent, but acute ISA volume was the only independent predictor for persistent ISA
(OR 3.19, 95% CI 1.43 – 7.12) and for massively delayed coverage (OR 1.37, 95% CI
1.09 – 1.74). Acute ISA size (estimated as ISA volume or maximal ISA distance per strut)
was an independent predictor of ISA persistence and of delayed healing at follow-up.
Maximal ISA distances 270 m post stent implantation appeared grossly covered and
spontaneously re-apposed in 100% of cases at follow-up; whilst maximal ISA distances
850 m) resulted in persisting ISA and grossly delayed coverage in 100% of cases.
Conclusions: The neointimal healing tends to reduce ISA, often integrating it completely
into the vessel wall and resulting in characteristic morphologic patterns. Coverage of ISA
segments is delayed with respect to well-apposed segments. The larger the size of acute
ISA, the larger the likelihood of persisting malapposed at follow-up and of delayed
healing.
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Background: Intravascular NIRS is well-validated for coronary lipid core plaque (LCP)
detection. Initial work has shown ability to differentiate LCP cap thickness by relative
cholesterol/collagen contribution to overall signal. This study assessed NIRS vs histology
LCP cap thickness in coronary autopsy specimens using improved multivariate methods,
reproducibility, and clinical applicability.
Methods: NIRS was performed through blood in 212 coronary segments from 84
autopsy hearts. Histologic sections were analyzed every 2mm, and fibrous cap thickness
in each LCP section was measured. Accuracy of classifying fibrous caps as thin
(65m), intermediate, or thick (400m) was tested for a combined-model approach
using cross-validation.
Results: Thin regions were present in 70/901 (7.8%) sections and thick regions were
present in 120/901 (13.3%) sections. The algorithm classified thin and thick fibrous cap
regions with an AUC of 0.78 (95% CI:0.72-0.85). Very good reproducibility for separate
catheter acquisitions was demonstrated: correlation coefficients of 0.96 for thin regions
and 0.92 for thick regions. A retrospective analysis of fibrous cap thickness conducted in
clinical NIRS scans containing LCPs, shows applicability of the technique to in vivo
images.
Conclusions: This novel catheter-based NIRS system already in clinical use to identify
LCPs in patients, accurately and reproducibly classified fibrous caps overlying LCP
through blood in coronary autopsy specimens. Assessment of fibrous cap thickness may
be of value in management of patients with coronary artery disease and development of
anti-athero drugs.
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Background: After the first-in-man REMEDEE Study report, the dual therapy COMBO
Stent (OrbusNeich Medical, FL, USA) was further evaluated for its in-vivo pro-healing
benefit and neointimal suppression as a DES in this Study.
Methods: In this prospective, single center study, 61 patients treated by COMBO Stent
(9 months DAPT) were randomly assigned to 4 monthly groups (2nd to 5th month,
1:2:2:1 ratio). OCT was performed sequentially 3 times at baseline PCI, early follow-up
in 4 monthly groups (for early stent coverage using 6 stringent Categories; every frame &
strut analyzed), and then 9 months (for OCT neointima analysis; every 5 frames). Clinical
event adjudication, core lab. QCA & OCT analyses were undertaken by Cardiovascular
Research Foundation, NY.
Results: 61 patients (32% DM) received 88 COMBO stents. From 2nd to 5th monthly
group, covered struts % increased significantly from 77.2%, 82.2%, 91.5% to 98.1%
(100% coverage at 150 days; refer to Figure). At 9 months, mean OCT neointimal
thickness was 0.135mm and area 1.259 mm2, with a corresponding QCA late loss of
0.31mm. At 9-month FU, 1 patient had non-ischemic angiographic stenosis treated by
simple ballooning; otherwise no other MACE (restenosis nor stent thrombosis) was
recorded to date, totaling a MACE rate of only 1.64% (1/61) throughout a mean FU period
of 508 days. Final core lab. results are pending.
Conclusions: The COMBO stent is the first DES with a healing profile established (rapid
strut coverage). The promising outcomes after almost 18 months FU appeared to support
the benefits of the dual therapy approach.
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Background: The optical coherence tomography (OCT) characteristics of in-stent
neointimal tissue have been associated with histological markers of healing. We aimed to
investigate the differences in neointimal characteristics based on OCT analysis of
Paclitaxel coated balloon (PCB) treatment versus POBA in the Iliofemoral territory of the
familial hypercholesterolemic swine model (FHS).
Methods: 14 Iliofemoral arterial segments of 7 FHS were balloon injured followed by a
BMS placement. At 14 days, the injured sites were treated with either a PCB or POBA
(control). OCT images, acquired at 28 days post inflation, were classified at every 2mm
according to previously published classification of neointimal types (homogeneous,
heterogeneous and layered). Quantitative morphometric evaluation of vessel, stent,
microvessel and peristrut low intensity areas (PLI) presence was also performed. A
multivariable logistic regression model was performed dividing the neointima into
homogeneous and non-homogeneous.
Results: AA total of 150 OCT cross sections were included in the final analysis. PCB
resulted in a reduction of percent area stenosis (%AS) by 50% (PCB: 3418% versus
POBA 6821%, p0.05). The homogeneous pattern was more frequent in PCB (25%)
than in the POBA group (3%, p0.001). Conversely, the layered pattern was more
prevalent in the POBA group (50.7% versus 4%, p0.001). The homogeneous pattern
correlated with less degree of neointimal formation [%AS: 16.685.3%, p0.001) than
the non-homogeneous group (heterogeneous: 49.0124.9% and layered: 67.2915.6%).
The presence of micro vessels (89% versus 58%, p0.001) and PLI (39% versus 24%,
p0.1) were more frequently found in the POBA group than in the PCB group. The only
independent predictor of non-homogeneous patterns was the %AS [OR (95% CI)] 
[3.98(1.21-13.09)].
Conclusions: In vivo OCT analysis suggests that the biological effect of Paclitaxel
delivered via DCB frequently results in the homogeneous development of neointimal
formation and lower frequency of PLI and micro-vessels compared to a POBA control.
These in vivo findings support the biological efficacy observed in clinical trials using this
technology.
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Background: Delayed arterial healing and late restenosis are a matter of concern of first
generation drug-eluting stents (DES). Although everolimus-eluting stent (EES) is a
widely-used second generation DES with biocompatible polymer, detailed time course of
vessel healing after implantation is still unclear.
Methods: We prospectively enrolled 128 de novo coronary artery lesions in 88 patients
treated with EES and performed follow-up (FUP) optical coherence tomography (OCT)
at various FUP timing regardless of symptoms. Lesions were divided into groups
according to the timing of FUP OCT: 3M (n12), 6M (n17), 9M (n63), 12M (n21),
15M group (n15). To assess unevenness of neointima thickness (NIT), neointimal
unevenness score (NUS: max NIT in the cross section/average NIT of the same cross
section) was calculated and averaged for each stent.
Results: Average NIT, neointima area, and %neointima obstruction progressively
increased within the first 12 months, and then slowed down at the level of around 160m
for NIT, 1.2 mm2 for neointima area, and 18% for %neointima obstruction. Also, %
uncovered and malapposed struts decreased along with Fup durations with a very few
incidences of those findings at 12M. NUS reached the highest level at the earliest FUP of
3 months and then reached a plateau 6M after stenting.
Conclusions: Progressive vessel healing was observed within the first year after EES
implantation. Neointimal progression within EES appears to slow down 1 year after
stenting with a very few incidences of uncovered and malapposed struts at that time.
TCT-295
Neointimal growth patterns after between biodegradable polymer biolimus-
eluting or permanent polymer everolimus-eluting stent implantation assessed
with newly developed “spread-out neointimal topography”: Results from
ISAR-TEST6 OCT trial
Tomohisa Tada1, Adnan Kastrati2, Robert Byrne2, Tibor Schuster3, Rezarta Cuni4,
Lamin King5, Salvatore Cassese6, Michael Joner7, Steffen Massberg4,
Albert Schömig6, Julinda Mehilli2
1Deutsches Herzzentrum Munich, Munich, Bayern, 2Deutsches Herzzentrum
Munich, Munich, Germany, 3Institute für Medizinische Statistik und Epidemiologie,
Munich, Bayern, 4Deutsches Herzzentrum, Munich, Bayern, 5Deutsches
Herzzentrum, Munich, Munich, Germany, 6Deutsches Herzzentrum, Munich,
BAVARIA, 7Deutsches Herzzentrum München, Munich, Germany
Background: Neointimal growth patterns of new generation drug-eluting stents are not
yet fully elucidated. We developed a new visualization method and compared neointimal
growth patterns between biodegradable polymer biolimus-eluting stent (BES) and
permanent polymer everolimus-eluting stent (EES) using optical coherence tomography
(OCT).
Methods: A total of 34 patients (41 lesions), who were randomly assigned to receive BES
(n15) or EES (n19) and performed OCT follow-up at 6-8 moths in the ISAR-
TEST6OCT trial were included in this analysis. The thickness of the neointima was
calculated circumferentially in the area between luminal side of the stent and lumen
contour semi-automatically. Neointimal thickness was measured a total of 287280 points
(135000 in BES, 152280 in EES). “Spread-out neointimal topography” was constructed
(Figure A) and neointimal growth patterns were compared between BES and EES.
Results: Inter-lesion analysis showed that mean neointimal thickness was significantly
lower in BES group than in EES group (39 [29-57] vs. 91 [59-118] m, p0.003, Figure
B). However Figure B showed a broader distribution of mean neointimal thickness in BES
group. Intra-lesion analysis showed more consistent suppression of neointima in the lesion
implanted BES comparison with the lesion implanted EES (50 [41-64] m vs. 71 [59-85]
m, p0.01).
Conclusions: A circumferential evaluation of the neointima using OCT showed that BES
as compared to EES lead to lower mean neointimal thickness, higher inter-lesion and
lower intra-lesion heterogeneity in terms of suppression of the neointimal hyperplasia.
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